COVID-19 Impact on Global Anemia Treatment Drugs Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: C2E6DA9B88B6EN
QYResearch

Abstracts

This report focuses on the global Anemia Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anemia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer, Inc.
• Amgen, Inc.
• Hoffmann-La Roche Ltd.
• Merck Sharp & Dohme Corp.
• Novartis AG
• Janssen Pharmaceutical
• Bayer AG
• AMAG Pharmaceuticals
• GlaxoSmithKline plc
• Akebia Therapeutics
• Vifor Pharma Management, Ltd.
• FibroGen, Inc.

Market segment by Type, the product can be split into

• Supplements
• Antibiotics
• Immunosuppressant
• Bone Marrow Stimulants
• Corticosteroids
• Gene Therapy
• Iron Chelating Agents

Market segment by Application, split into

• Iron deficiency anemia
• Thalassemia
• Aplastic anemia
• Hemolytic anemia
• Sickle cell anemia
• Pernicious anemia

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anemia Treatment Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Anemia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anemia Treatment Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anemia Treatment Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anemia Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Supplements
  1.4.3 Antibiotics
  1.4.4 Immunosuppressant
  1.4.5 Bone Marrow Stimulants
  1.4.6 Corticosteroids
  1.4.7 Gene Therapy
  1.4.8 Iron Chelating Agents
1.5 Market by Application
  1.5.1 Global Anemia Treatment Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Iron deficiency anemia
  1.5.3 Thalassemia
  1.5.4 Aplastic anemia
  1.5.5 Hemolytic anemia
  1.5.6 Sickle cell anemia
  1.5.7 Pernicious anemia
1.6 Coronavirus Disease 2019 (Covid-19): Anemia Treatment Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Anemia Treatment Drugs Industry
    1.6.1.1 Anemia Treatment Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Anemia Treatment Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Anemia Treatment Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anemia Treatment Drugs Market Perspective (2015-2026)
2.2 Anemia Treatment Drugs Growth Trends by Regions
  2.2.1 Anemia Treatment Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anemia Treatment Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Anemia Treatment Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anemia Treatment Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Anemia Treatment Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anemia Treatment Drugs Players by Market Size
  3.1.1 Global Top Anemia Treatment Drugs Players by Revenue (2015-2020)
  3.1.2 Global Anemia Treatment Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anemia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anemia Treatment Drugs Market Concentration Ratio
  3.2.1 Global Anemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anemia Treatment Drugs Revenue in 2019
3.3 Anemia Treatment Drugs Key Players Head office and Area Served
3.4 Key Players Anemia Treatment Drugs Product Solution and Service
3.5 Date of Enter into Anemia Treatment Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anemia Treatment Drugs Historic Market Size by Type (2015-2020)
4.2 Global Anemia Treatment Drugs Forecasted Market Size by Type (2021-2026)

5 ANEMIA TREATMENT DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anemia Treatment Drugs Market Size by Application (2015-2020)
5.2 Global Anemia Treatment Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anemia Treatment Drugs Market Size (2015-2020)
6.2 Anemia Treatment Drugs Key Players in North America (2019-2020)
6.3 North America Anemia Treatment Drugs Market Size by Type (2015-2020)
6.4 North America Anemia Treatment Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anemia Treatment Drugs Market Size (2015-2020)
7.2 Anemia Treatment Drugs Key Players in Europe (2019-2020)
7.3 Europe Anemia Treatment Drugs Market Size by Type (2015-2020)
7.4 Europe Anemia Treatment Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Anemia Treatment Drugs Market Size (2015-2020)
8.2 Anemia Treatment Drugs Key Players in China (2019-2020)
8.3 China Anemia Treatment Drugs Market Size by Type (2015-2020)
8.4 China Anemia Treatment Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anemia Treatment Drugs Market Size (2015-2020)
9.2 Anemia Treatment Drugs Key Players in Japan (2019-2020)
9.3 Japan Anemia Treatment Drugs Market Size by Type (2015-2020)
9.4 Japan Anemia Treatment Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anemia Treatment Drugs Market Size (2015-2020)
10.2 Anemia Treatment Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anemia Treatment Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Anemia Treatment Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Anemia Treatment Drugs Market Size (2015-2020)
11.2 Anemia Treatment Drugs Key Players in India (2019-2020)
11.3 India Anemia Treatment Drugs Market Size by Type (2015-2020)
11.4 India Anemia Treatment Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anemia Treatment Drugs Market Size (2015-2020)
12.2 Anemia Treatment Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Anemia Treatment Drugs Market Size by Type (2015-2020)
12.4 Central & South America Anemia Treatment Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer, Inc.
  13.1.1 Pfizer, Inc. Company Details
  13.1.2 Pfizer, Inc. Business Overview and Its Total Revenue
  13.1.3 Pfizer, Inc. Anemia Treatment Drugs Introduction
  13.1.4 Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020))
  13.1.5 Pfizer, Inc. Recent Development
13.2 Amgen, Inc.
  13.2.1 Amgen, Inc. Company Details
  13.2.2 Amgen, Inc. Business Overview and Its Total Revenue
  13.2.3 Amgen, Inc. Anemia Treatment Drugs Introduction
  13.2.4 Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.2.5 Amgen, Inc. Recent Development
13.3 Hoffmann-La Roche Ltd.
  13.3.1 Hoffmann-La Roche Ltd. Company Details
  13.3.2 Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.3.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Introduction
  13.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.3.5 Hoffmann-La Roche Ltd. Recent Development
13.4 Merck Sharp & Dohme Corp.
  13.4.1 Merck Sharp & Dohme Corp. Company Details
  13.4.2 Merck Sharp & Dohme Corp. Business Overview and Its Total Revenue
  13.4.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Introduction
  13.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.4.5 Merck Sharp & Dohme Corp. Recent Development
13.5 Novartis AG
  13.5.1 Novartis AG Company Details
  13.5.2 Novartis AG Business Overview and Its Total Revenue
  13.5.3 Novartis AG Anemia Treatment Drugs Introduction
  13.5.4 Novartis AG Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.5.5 Novartis AG Recent Development
13.6 Janssen Pharmaceutical
  13.6.1 Janssen Pharmaceutical Company Details
  13.6.2 Janssen Pharmaceutical Business Overview and Its Total Revenue
  13.6.3 Janssen Pharmaceutical Anemia Treatment Drugs Introduction
  13.6.4 Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.6.5 Janssen Pharmaceutical Recent Development
13.7 Bayer AG
  13.7.1 Bayer AG Company Details
  13.7.2 Bayer AG Business Overview and Its Total Revenue
  13.7.3 Bayer AG Anemia Treatment Drugs Introduction
  13.7.4 Bayer AG Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.7.5 Bayer AG Recent Development
13.8 AMAG Pharmaceuticals
  13.8.1 AMAG Pharmaceuticals Company Details
  13.8.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 AMAG Pharmaceuticals Anemia Treatment Drugs Introduction
  13.8.4 AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.8.5 AMAG Pharmaceuticals Recent Development
13.9 GlaxoSmithKline plc
  13.9.1 GlaxoSmithKline plc Company Details
  13.9.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.9.3 GlaxoSmithKline plc Anemia Treatment Drugs Introduction
  13.9.4 GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.9.5 GlaxoSmithKline plc Recent Development
13.10 Akebia Therapeutics
  13.10.1 Akebia Therapeutics Company Details
  13.10.2 Akebia Therapeutics Business Overview and Its Total Revenue
  13.10.3 Akebia Therapeutics Anemia Treatment Drugs Introduction
  13.10.4 Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2015-2020)
  13.10.5 Akebia Therapeutics Recent Development
13.11 Vifor Pharma Management, Ltd.
  10.11.1 Vifor Pharma Management, Ltd. Company Details
  10.11.2 Vifor Pharma Management, Ltd. Business Overview and Its Total Revenue
  10.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Introduction
  10.11.4 Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020)
  10.11.5 Vifor Pharma Management, Ltd. Recent Development
13.12 FibroGen, Inc.
  10.12.1 FibroGen, Inc. Company Details
  10.12.2 FibroGen, Inc. Business Overview and Its Total Revenue
  10.12.3 FibroGen, Inc. Anemia Treatment Drugs Introduction
  10.12.4 FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020)
  10.12.5 FibroGen, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anemia Treatment Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Anemia Treatment Drugs Revenue
Table 3. Ranking of Global Top Anemia Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anemia Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Supplements
Table 6. Key Players of Antibiotics
Table 7. Key Players of Immunosuppressant
Table 8. Key Players of Bone Marrow Stimulants
Table 9. Key Players of Corticosteroids
Table 10. Key Players of Gene Therapy
Table 11. Key Players of Iron Chelating Agents
Table 12. COVID-19 Impact Global Market: (Four Anemia Treatment Drugs Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for Anemia Treatment Drugs Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for Anemia Treatment Drugs Players to Combat Covid-19 Impact
Table 17. Global Anemia Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global Anemia Treatment Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global Anemia Treatment Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global Anemia Treatment Drugs Market Share by Regions (2015-2020)
Table 21. Global Anemia Treatment Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global Anemia Treatment Drugs Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. Anemia Treatment Drugs Market Growth Strategy
Table 27. Main Points Interviewed from Key Anemia Treatment Drugs Players
Table 28. Global Anemia Treatment Drugs Revenue by Players (2015-2020) (Million US$)
Table 29. Global Anemia Treatment Drugs Market Share by Players (2015-2020)
Table 30. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2019)
Table 31. Global Anemia Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players Anemia Treatment Drugs Product Solution and Service
Table 34. Date of Enter into Anemia Treatment Drugs Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 37. Global Anemia Treatment Drugs Market Size Share by Type (2015-2020)
Table 38. Global Anemia Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 39. Global Anemia Treatment Drugs Market Size Share by Application (2015-2020)
Table 40. Global Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. Global Anemia Treatment Drugs Market Size Share by Application (2021-2026)
Table 42. North America Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 43. North America Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 44. North America Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. North America Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 46. North America Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. North America Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 48. Europe Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 50. Europe Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. Europe Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 52. Europe Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. Europe Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 54. China Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 55. China Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 56. China Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. China Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 58. China Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. China Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 60. Japan Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 62. Japan Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Japan Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 64. Japan Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Japan Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 66. Southeast Asia Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 67. Southeast Asia Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 68. Southeast Asia Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. Southeast Asia Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 70. Southeast Asia Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. Southeast Asia Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 72. India Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 73. India Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 74. India Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. India Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 76. India Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. India Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 78. Central & South America Key Players Anemia Treatment Drugs Revenue (2019-2020) (Million US$)
Table 79. Central & South America Key Players Anemia Treatment Drugs Market Share (2019-2020)
Table 80. Central & South America Anemia Treatment Drugs Market Size by Type (2015-2020) (Million US$)
Table 81. Central & South America Anemia Treatment Drugs Market Share by Type (2015-2020)
Table 82. Central & South America Anemia Treatment Drugs Market Size by Application (2015-2020) (Million US$)
Table 83. Central & South America Anemia Treatment Drugs Market Share by Application (2015-2020)
Table 84. Pfizer, Inc. Company Details
Table 85. Pfizer, Inc. Business Overview
Table 86. Pfizer, Inc. Product
Table 87. Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 88. Pfizer, Inc. Recent Development
Table 89. Amgen, Inc. Company Details
Table 90. Amgen, Inc. Business Overview
Table 91. Amgen, Inc. Product
Table 92. Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 93. Amgen, Inc. Recent Development
Table 94. Hoffmann-La Roche Ltd. Company Details
Table 95. Hoffmann-La Roche Ltd. Business Overview
Table 96. Hoffmann-La Roche Ltd. Product
Table 97. Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 98. Hoffmann-La Roche Ltd. Recent Development
Table 99. Merck Sharp & Dohme Corp. Company Details
Table 100. Merck Sharp & Dohme Corp. Business Overview
Table 101. Merck Sharp & Dohme Corp. Product
Table 102. Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 103. Merck Sharp & Dohme Corp. Recent Development
Table 104. Novartis AG Company Details
Table 105. Novartis AG Business Overview
Table 106. Novartis AG Product
Table 107. Novartis AG Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 108. Novartis AG Recent Development
Table 109. Janssen Pharmaceutical Company Details
Table 110. Janssen Pharmaceutical Business Overview
Table 111. Janssen Pharmaceutical Product
Table 112. Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 113. Janssen Pharmaceutical Recent Development
Table 114. Bayer AG Company Details
Table 115. Bayer AG Business Overview
Table 116. Bayer AG Product
Table 117. Bayer AG Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 118. Bayer AG Recent Development
Table 119. AMAG Pharmaceuticals Business Overview
Table 120. AMAG Pharmaceuticals Product
Table 121. AMAG Pharmaceuticals Company Details
Table 122. AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 123. AMAG Pharmaceuticals Recent Development
Table 124. GlaxoSmithKline plc Company Details
Table 125. GlaxoSmithKline plc Business Overview
Table 126. GlaxoSmithKline plc Product
Table 127. GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 128. GlaxoSmithKline plc Recent Development
Table 129. Akebia Therapeutics Company Details
Table 130. Akebia Therapeutics Business Overview
Table 131. Akebia Therapeutics Product
Table 132. Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 133. Akebia Therapeutics Recent Development
Table 134. Vifor Pharma Management, Ltd. Company Details
Table 135. Vifor Pharma Management, Ltd. Business Overview
Table 136. Vifor Pharma Management, Ltd. Product
Table 137. Vifor Pharma Management, Ltd. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 138. Vifor Pharma Management, Ltd. Recent Development
Table 139. FibroGen, Inc. Company Details
Table 140. FibroGen, Inc. Business Overview
Table 141. FibroGen, Inc. Product
Table 142. FibroGen, Inc. Revenue in Anemia Treatment Drugs Business (2015-2020) (Million US$)
Table 143. FibroGen, Inc. Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anemia Treatment Drugs Market Share by Type: 2020 VS 2026
Figure 2. Supplements Features
Figure 3. Antibiotics Features
Figure 4. Immunosuppressant Features
Figure 5. Bone Marrow Stimulants Features
Figure 6. Corticosteroids Features
Figure 7. Gene Therapy Features
Figure 8. Iron Chelating Agents Features
Figure 9. Global Anemia Treatment Drugs Market Share by Application: 2020 VS 2026
Figure 10. Iron deficiency anemia Case Studies
Figure 11. Thalassemia Case Studies
Figure 12. Aplastic anemia Case Studies
Figure 13. Hemolytic anemia Case Studies
Figure 14. Sickle cell anemia Case Studies
Figure 15. Pernicious anemia Case Studies
Figure 16. Anemia Treatment Drugs Report Years Considered
Figure 17. Global Anemia Treatment Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Anemia Treatment Drugs Market Share by Regions: 2020 VS 2026
Figure 19. Global Anemia Treatment Drugs Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Anemia Treatment Drugs Market Share by Players in 2019
Figure 22. Global Top Anemia Treatment Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Treatment Drugs as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Anemia Treatment Drugs Revenue in 2019
Figure 24. North America Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Anemia Treatment Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 33. Amgen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Amgen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 35. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 37. Merck Sharp & Dohme Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 39. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Novartis AG Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 41. Janssen Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Janssen Pharmaceutical Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 43. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Bayer AG Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 45. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. AMAG Pharmaceuticals Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 47. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 49. Akebia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Akebia Therapeutics Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 51. Vifor Pharma Management, Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Vifor Pharma Management, Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 53. FibroGen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. FibroGen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed